Please use this identifier to cite or link to this item:
|Title:||De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy||Authors:||CLAES, Luc
Van Broeckhoven, C.
De Jonghe, P.
|Issue Date:||2001||Publisher:||UNIV CHICAGO PRESS||Source:||American journal of human genetics, 68(6). p. 1327-1332||Abstract:||Severe myoclonic epilepsy of infancy (SMEI) is a rare disorder that occurs in isolated patients. The disease is characterized by generalized tonic, clonic, and tonic-clonic seizures that are initially induced by fever and begin during the first year of life. Later, patients also manifest other seizure types, including absence, myoclonic, and simple and complex partial seizures. Psychomotor development stagnates around the second year of life. Missense mutations in the gene that codes for a neuronal voltage-gated sodium-channel alpha -subunit (SCN1A) were identified in families with generalized epilepsy with febrile seizures plus (GEFS+). GEFS+ is a mild type of epilepsy associated with febrile and afebrile seizures. Because both GEFS+ and SMEI involve fever-associated seizures, we screened seven unrelated patients with SMEI for mutations in SCN1A. We identified a mutation in each patient: four had frameshift mutations, one had a nonsense mutation, one had a splice-donor mutation, and one had a missense mutation. All mutations are de novo mutations and were not observed in 184 control chromosomes.||Document URI:||http://hdl.handle.net/1942/4987||ISSN:||0002-9297||e-ISSN:||1537-6605||ISI #:||000169094600003||Category:||A1||Type:||Journal Contribution|
|Appears in Collections:||Research publications|
Show full item record
WEB OF SCIENCETM
checked on May 22, 2022
checked on May 24, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.